DOCSLIB.ORG

Atrial Natriuretic Peptide Inhibits Renin Release from Juxtaglomerular Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Atrial Natriuretic Peptide Inhibits Renin Release from Juxtaglomerular Cells Proc. Natl. Acad. Sci. USA Vol. 83, pp. 4769-4773, July 1986 Cell Biology Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process ARMIN KURTZ*, ROBERTO DELLA BRUNA*, JOSEF PFEILSCHIFTER*, ROLAND TAUGNERt, AND CHRISTIAN BAUER* *Physiologisches Institut der Universitit Zfrich, Winterthurerstrasse 190, 8057 Zurich, Switzerland; and tPhysiologisches Institut der Universitat Heidelberg, Im Neuenheimer Feld 326, D-6900 Heidelberg, Federal Republic of Germany Communicated by Robert E. Forster II, March 3, 1986 ABSTRACT We have exmined the effect of a synthetic MATERIALS AND METHODS analogue of human et-atrial natriuretic peptide (ANP), APH, on renin release in cultured renal juxtaglomerular cells (JGA Cell Culture. Isolation ofjuxtaglomerular cells was essen- cells). Using cell cultures containing 80-90% renal juxtaglom- tially as described (8, 9). In brief, rat kidneys were perfused erular cells, we found that ANP (10-13-10-9 M) strongly in situ with citrate buffer. After exstirpation of the kidneys, inhibited renin release from the cells in a dose-dependent renal cortex was minced and subsequently incubated with a fashion (ki, 10 pM) to about 10% of control. Inhibition of renin collagenase-trypsin solution. The suspension was poured release by ANP was paralleled by an increase in cellular cGMP over a 22-ptm screen, and single cells passing the sieve were levels; while in the presence of the cGMP-phosphodiesterase washed with culture medium. As described (9), cell cultures inhibitor M&B 22948 (1 mM), concentrations of ANP lower by containing about 50% juxtaglomerular cells can be obtained a factor of 100 were required to obtain the same effects on renin by culturing these single cells. To improve the enrichment of release and cGMP levels. The guanylate cyclase inhibitor juxtaglomerular cells, we centrifuged the cells in a Percoll- methylene blue (10 IAM), on the other hand, shifted the density gradient. About 15 x 106 cells were mixed with 30 ml dose-response curves for renin release and cGMP levels to of an isotonic 25% (vol/vol) Percoll solution and centrifuged 100-fold higher concentrations of ANP. Neither the influx of at 15,000 x g in a vertical rotor (SV-288, Sorvall) for 30 min. 45Ca into the cells nor the intracellular quin-2 signal, which is Four different bands with densities of 1.02 g/ml, 1.05 g/ml, a measure for changes ofintracellular Ca concentration, was in 1.06 g/ml, and 1.13 g/ml were regularly obtained. Table 1 any way altered by ANP. Our results suggest that ANP inhibits gives typical values for the distribution ofprotein and specific renin release fromjuxtaglomerular cells by a cGMP-dependent renin activity within the gradient. Band III cells (1.06 g/ml) process that does not involve changes in intracellular calcium. were incubated with culture medium [RPMI 1640, 25 mM Hepes, streptomycin at 100 tug/ml, penicillin at 100 units/ml, Two major effects ofatrial natriuretic peptide (ANP) on renal 2% (vol/vol) fetal bovine serum] at 370C in 5% C02/95% air. function have been described, namely the enhancement of All experiments as described below were performed on the sodium and water excretion (cf. refs. 1 and 2) and the second day of culture. suppression of renin release (3-5). Inhibition of renin release Renin Demonstration by Immunofluorescence. Immuno- by ANP leading to a diminished formation of angiotensin II fluorescence staining for renin was done exactly as described (AI) would result in decreased vascular tone and impaired (9). In brief, cell cultures were fixed in 4% (wt/vol) aldosterone secretion. Both effects are of physiological paraformaldehyde/Dulbecco's phosphate-buffered saline importance during states of expanded extracellular volume, (PBS). After 5 min in 10% (vol/vol) normal swine in which enhanced release of ANP from the atrium is serum/0.1% bovine serum albumin/PBS, the cultures were observed (6, 7). incubated with rabbit antiserum against rat renin diluted The mechanism by which ANP inhibits renal renin release 1:200 in 10% (vol/vol) normal swine serum/PBS. After is as yet a matter of debate (2). In view of the increased rinsing in PBS, a 30-min incubation followed with tetra- filtration rate of NaCl caused by the ANP, which leads to an methylrhodamine B isothiocyanate (TRITC)-conjugated goat increased NaCl load at the macula densa, it has been anti-rabbit IgG (1:500, Sigma). The specificity of the im- speculated that ANP inhibits renin release fromjuxtaglomer- munoreaction was tested with the usual control procedures ular cells via the macula densa receptor (3, 4). However, a (9). Immunofluorescence was examined using a Polyvar direct effect of ANP on juxtaglomerular cells could not be fluorescence microscope (Reichert-Jung, Vienna, Austria). excluded on the basis of experimental evidence. Therefore, Rabbit antiserum against rat renin, used in the studies, was we wanted to investigate whether or not ANP directly a generous gift of M. Celio (Zurich) who obtained it from T. inhibits renin release by renal juxtaglomerular cells. Inagami (Nashville, TN). For immunocytochemical demon- We have developed a cell culture system that contains stration and localization with the protein A/gold technique, around 50% juxtaglomerular cells (8, 9). We now have pellets of 106 cells were fixed in 1% glutaraldehyde and improved this method by including a Percoll-density gradient embedded in London White resin (London Resin, Basing- in the cell preparation procedure. As a result, cell cultures stoke, England). Ultrathin sections were immunostained for can be obtained that contain regularly between 80 and 90% renin as described by Taugner et al. (10). Rabbit antiserum juxtaglomerular cells. against rat renin used in these studies was a generous gift We found that ANP strongly inhibits renin release from from E. Hackenthal. these cultured cells and, furthermore, obtained strong evi- Renin Release. Renin release from the cultured cells was dence that the inhibitory effect ofANP is mediated by cGMP determined exactly as described (8). In brief, the culture and does not involve an increase in intracellular calcium. medium was replaced with prewarmed, Hepes-buffered sa- line [132 mM NaCl, 5 mM KCl, 0.8 mM MgSO4, 2 mM CaCl2, The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" Abbreviations: ANP, atrial natriuretic peptide; Al, angiotensin I; in accordance with 18 U.S.C. §1734 solely to indicate this fact. All, angiotension II; [Ca]j, intracellular Ca2+ concentration. 4769 Downloaded by guest on September 29, 2021 4770 Cell Biology: Kurtz et al. Proc. Natl. Acad. Sci. USA 83 (1986) Table 1. Protein distribution and specific renin activity of cells separated by a 25% (vol/vol) Percoll gradient Specific renin activity, Density, Protein, ng of AI per hr Band g/ml mg per mg of protein I 1.02 2.01 ± 0.35 30 ± 11 II 1.05 3.36 ± 0.75 143 ± 60 III 1.06 0.51 ± 0.19 1170 ± 280 IV 1.13 3.27 ± 0.62 7 ± 5 Data are mean ± SEM of three experiments. 10 mM NaOAc, 2 mM NaH2PO4, 10 mM glucose, 20 mM Hepes (pH 7.2)]; and the culture dishes were placed on a heating block at 370C. The renin secretion rate was calculated from the linear increase of the renin activity of the cell- conditioned buffer before and 10, 20, and 30 min after addition of the agents. Renin Activity Assay. Renin activity was determined by its ability to generate angiotensin I (AI) from the plasma of bilaterally nephrectomized rats exactly as described (11). AI was determined by radioimmunoassay (Isotopen Dienst West, Teufen, Switzerland). Intracellular cGMP Levels. Intracellular cGMP concentra- tions were examined under the same experimental conditions as the renin release. Five minutes after the addition of the agents, the buffer was removed from the cultures, and the dishes were placed on an ice block. After the addition of 0.4 ml of ice-cold 5 mM potassium phosphate, 0.2 mM EDTA, 0.5 mM 3-isobutyl-methylxanthine, and 150 mM KCl (pH 6.8), the cells were scraped off with a Teflon policeman. The FIG. 1. Microphotograph of cultured cells on second day of cell suspension so obtained was sonicated, boiled for 5 min, culture. (Upper) Phase-contrast and (Lower) immunofluorescence and centrifuged. An aliquot was removed from the sonicated micrographs of cells treated with rabbit anti-rat renin and TRITC- cell suspension for protein determination. The supernatants labeled goat anti-rabbit y-globulin. (x2902.) were assayed for cGMP using a cGMP radioimmunoassay (New England Nuclear). have also shown elsewhere (9), the round cells that stain for 45Ca-Uptake. 45Ca-uptake into the cultured cells was de- renin contain prominent renin granules (Fig. 2). We, there- termined exactly as described (8). fore, conclude that these cells are juxtaglomerular cells. The Intracellular Ca2' Measurement. Intracellular Ca2+, [Ca]i, cellular renin activity of the cultured cells used in this study was measured using quin-2. About 2 x 107 cells were was between 100-200 ng ofAl per hr per mg ofprotein on the incubated with 25 uM quin-2 AM [tetrakis(acetoxymethyl) second day of culture. The renin activity in the culture ester of quin-2] in RPMI 1640 for 20 min followed by another medium was between 1 and 2.6 ,g of AI per hr per mg of 40-min incubation with 4 vol ofmedium. After the incubation cellular protein. period, aliquots of 1 x 106 cells were washed twice and Effect of ANP on the Cultured Cells. Fig. 3 shows the effect resuspended in Hepes-buffered saline. Fluorescence ofquin- of ANP on the spontaneous renin release from the cultured 2-loaded cells was measured at 37°C in a Perkin-Elmer cells.
Load more

Recommended publications
  • Aldosterone and Parathyroid Hormone: Evidence for a Clinically Relevant Relationship
    Journal of Endocrinology and Thyroid Research ISSN: 2573-2188 Review Article J Endocrinol Thyroid Res Volume 4 Issue 3 - May 2019 Copyright © All rights are reserved by Vismay Naik DOI: 10.19080/JETR.2019.04.555637 Aldosterone and Parathyroid Hormone: Evidence for a Clinically Relevant Relationship Vismay Naik* PG Diploma in Endocrinology and Diabetes, Ashirvad Heart and Diabetes Centre, India Submission: April 13, 2019; Published: May 06, 2019 *Corresponding author: Vismay Naik, MD, MRCP(UK), PG Diploma in Endocrinology and Diabetes, Ashirvad Heart and Diabetes Centre, India Introduction hyperparathyroidism due to increased renal and faecal calcium A ‘new endocrine axis’, involving the bi-directional relati- excretion. PTH is increased as a result of the MR (mineralocorticoid onship between the parathyroid hormone (PTH) and the renin– receptor) mediated calciuretic and magnesiuretic effects, with a angiotensin–aldosterone system (RAAS) has been established trend towards hypocalcemia, hypomagnesemia and the direct recently. Individually these have long been recognized, althou- effects of aldosterone on parathyroid cells via binding to the MR. gh it is only in recent times that we are realizing the interplay Moreover, the angiotensin II receptor is expressed by human between the two and the corresponding effects this has on the parathyroid tissue, and angiotensin may therefore directly physiological and pathological roles within the body. Other cal- stimulate PTH secretion [6]. ciotropic hormones such as Vitamin D are also impacting on this relationship [1]. This report aims to highlight the cyclic nature of RAAS and Vitamin D these relationships, through the physiological pathways, which Aldosterone acts through the mineralocorticoid receptor, will then lead into pathological disease in multiple areas such as which belongs to the same superfamily of nuclear receptors as heart failure, cardiovascular health and bone homeostasis.
    [Show full text]
  • Hypertension: Shall We Focus on Adipose Tissue?
    www.jasn.org EDITORIALS Hypertension: Shall We Focus associated with incident hypertension among women with- out diabetes. The authors prospectively studied 872 women on Adipose Tissue? without diabetes or hypertension from the Nurses’ Health Study. After a follow-up of 14 years, 361 (41.4%) women Simona Bo and Paolo Cavallo-Perin developed hypertension. Plasma resistin values were signif- Department of Internal Medicine, University of Turin, Turin, Italy icantly associated with incident hypertension: The highest resistin tertile conferred a 75% higher risk for hypertension J Am Soc Nephrol 21: 1067–1068, 2010. doi: 10.1681/ASN.2010050524 than the lowest (relative risk 1.75; 95% confidence interval 1.19 to 2.56). The relative risk did not substantially change after adjustment for multiple potential metabolic and nu- Adipose tissue is an active endocrine organ that produces sub- tritional confounding factors and for other adipokines. The stances having local and systemic actions on blood vessels, kid- risk was greater among older women. In a secondary analy- neys, and the heart. Leptin, adiponectin, resistin, angiotensin sis, inflammatory and endothelial biomarkers were mea- ␣ II, adipsin, TNF- , IGF-1, plasminogen-activator inhibitor 1, sured in a subset of women. Resistin levels were significantly and prostaglandins compose an incomplete list.1 associated with both groups of biomarkers. After further Resistin, an adipokine belonging to the cysteine-rich secre- adjustment for C-reactive protein, IL-6, soluble TNF recep- tory protein family, was described as an adipocyte-derived tor 2, intercellular adhesion molecule 1, vascular adhesion polypeptide that links obesity and insulin resistance in mice2; molecule 1, and E-selectin, resistin concentrations re- however, striking differences in the genomic organization and mained positively associated with an increased risk for inci- cellular source of resistin in rodents versus humans and the dent hypertension.
    [Show full text]
  • Why Is Plasma Renin Activity Lower in Populations of African Origin?
    Journal of Human Hypertension (2001) 15, 17–25 2001 Macmillan Publishers Ltd All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh REVIEW ARTICLE Why is plasma renin activity lower in populations of African origin? GA Sagnella Blood Pressure Unit, St George’s Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK Plasma renin activity is significantly lower in black the molecular level suggests that the lower PRA may people compared with whites independent of age and arise from gene variation in the renal epithelial sodium blood pressure status. The lower PRA appears to be due channel. The functional significance of the lower PRA in to a reduction in the rate of secretion of renin but the relation to the different pattern of cardiovascular and exact mechanistic events underlying such differences in renal disease between blacks and whites remains renin release between blacks and whites are still not unclear. Moreover, direct investigations of pre-treat- fully understood. Nevertheless, given the paramount ment renin status in hypertensive blacks in relation to importance of the renin-angiotensin system in the con- blood pressure response have demonstrated that the trol of sodium balance, a most likely explanation is that pre-treatment PRA is not a good index of subsequent the lower renin is a consequence of differences in renal blood pressure response to pharmacological treatment. sodium handling between blacks and whites. The lower Nevertheless, the blood pressure reduction to short PRA does not reflect differences in dietary sodium term sodium restriction is greater in blacks compared intake but the evidence available suggests that the low with whites and, in the black subjects, the greater PRA could be part of the corrective mechanisms reduction in blood pressure to sodium restriction designed to maintain sodium balance in the presence appears to be related, at least in part, to the decreased of an increased tendency for sodium retention in black responsiveness of the renin-angiotensin system.
    [Show full text]
  • High and Non-Suppressible Plasma Renin Activity in a Patient with Aldosterone Producing Adenoma: Pathophysiologic and Diagnostic Implications
    Journal of Human Hypertension (1999) 13, 75–78 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh CASE REPORT High and non-suppressible plasma renin activity in a patient with aldosterone producing adenoma: pathophysiologic and diagnostic implications E Shyong Tai and PHK Eng Department of Endocrinology, Singapore General Hospital, Singapore We describe a case of primary aldosteronism due to an possible pathophysiological causes of a rise in PRA in aldosterone producing adenoma with high and non-sup- this clinical setting and suggest that underlying arteri- pressible plasma renin activity (PRA). She had sup- olar disease due to prolonged hypertension may be the pressed PRA at initial diagnosis. This rose above the cause of increased and non-suppressible PRA in pri- reference range for normal individuals over a period of mary aldosteronism. 7 years with untreated hypertension. We discuss the Keywords: primary aldosteronism; plasma renin activity; diagnosis Introduction Case report Primary aldosteronism is classically associated with Our patient was a 34-year-old woman who was hypertension, hypokalaemia and suppressed plasma found to have hypertension during the fifteenth renin activity (PRA). Most cases are due to an aldo- week of pregnancy. Plasma aldosterone was sterone producing adenoma (APA). We present a 2039 pmol/l, PRA Ͻ0.15 ␮g/l/h and a diagnosis of case of prolonged, untreated, primary aldosteronism primary aldosteronism was made. Following the due to an APA. She had suppressed PRA at the time delivery of her child, she defaulted follow-up and of diagnosis, which became elevated and non-sup- was not treated with any antihypertensives nor pot- pressible by intravenous salt loading.
    [Show full text]
  • Aldosterone-Renin Ratio (Arr)
    RENIN -ALDOSTERONE PROFILING: ALDOSTERONE-RENIN RATIO (ARR) 1. Obtain a morning specimen for serum aldosterone (redtop tube) and plasma renin (lavender-top) tube from an upright patient sitting for a period of 15 min prior to (being seated for) blood drawing. Fasting is not required and no salt restriction is necessary. 2. Spironolactone. The ratio cannot be assessed in patients receiving spironlactone. If primary aldosteronism (PA) is suspected in a patient receiving this drug, treatment should be discontinued for 4-6 weeks (1). 3. Hypokalemia should be corrected before ARR is measured as a low K will lower aldosterone and can lead to a falsely negative ARR (1). 4. Preferred antihypertensives that have a minimal effect on the ARR are doxazozin (Cardura), prazosin (Minipress), verapramil slow release, or hydralazine, singly or in combination for one month before sampling (1). 5. False-positive ARR: Beta-blockers, clonidine, methyldopa, and NSAID’s lower levels of renin and can cause a falsely positive ARR (1). A minimum 3-day cessation prior to sampling is recommended (3). The renin direct assay is also lower in patients on oral contraceptives and hormone replacement therapy potentially causing the ARR to be falsely increased. Measurement of plasma renin activity is preferred in this situation, calculating the aldosterone/PRA ratio (positive if >20/1). 6. False-negative ARR: Diuretics cause false negatives by causing K loss lowering aldosterone and stimulating renin through volume loss. Angiotensin blockers (ARB’s), ACE inhibitors, and some calcium channel blockers raise renin and can cause false negatives (1). A minimum three-day cessation prior to sampling is recommended (3).
    [Show full text]
  • The Renin-Angiotensin System and the Heart: a Historical Review Heart: First Published As 10.1136/Hrt.76.3 Suppl 3.7 on 1 November 1996
    Heart (Supplement 3) 1996;76:7-12 7 The renin-angiotensin system and the heart: a historical review Heart: first published as 10.1136/hrt.76.3_Suppl_3.7 on 1 November 1996. Downloaded from Stephen J Cleland, John L Reid Early observations on a possible link effect but was in fact an enzyme. The names between the kidney and the "hypertensin""l and "angiotonin"12 were given cardiovascular system to the pressor substance formed from the renin In 1836 an English clinician Richard Bright substrate by the enzymatic action of renin. observed that patients dying with contracted Subsequently, it was agreed that the term kidneys often had a hard, full pulse and cardiac "angiotensin" would be used to describe this hypertrophy.' In 1889 Brown-Sequard, the substance. During this period the potential for "father" of endocrinology, showed that injec- pathological effects of renin was recognised. tions of extracts from guinea pig testicles were Winternitz described necrotising arteriolar able to produce systemic effects of vigour and lesions in animals which had undergone renal the perception of rejuvenation.2 On this back- artery ligation and also in nephrectomised ani- ground, in 1896 the Finnish physiologist mals which had been given kidney extracts.'3 Robert Tigerstedt and his student Per Finally, the relevance of renal control of blood Bergman began to explore the possibility that pressure in man was described by Young who, kidney extracts from rabbits may have some in 1936, cured a case of malignant hyperten- systemic effects on the cardiovascular system. sion by removing an ischaemic kidney.'4 In 1898 their classic paper was published showing that intravenous injection of these renal extracts exerted a pressor effect.
    [Show full text]
  • Plasma Renin Activity and Pro-B-Type Natriuretic Peptide Levels in Different Atrial Fibrillation Types
    Original Investigation Özgün Araşt›rma 317 Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types Farklı atriyal fibrilasyon türlerinde plazma renin aktivitesi ve pro-B-tipi natriüretik peptit düzeyleri Abdullah Doğan, Ömer Gedikli1, Mehmet Özaydın, Gürkan Acar2 Department of Cardiology, Faculty of Medicine, Süleyman Demirel University, Isparta 1Department of Cardiology, Faculty of Medicine, Karadeniz Technical University, Trabzon 2Department of Cardiology, Faculty of Medicine, Sütçü Imam University, Kahramanmaraş, Turkey ABSTRACT Objective: Renin-angiotensin system may be activated during atrial fibrillation (AF). Our aim was to evaluate plasma renin activity (PRA) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in patients with different AF types who had normal left ventricular (LV) systolic function. Methods: This cross-sectional study included 97 patients with recent (≤7 days), persistent (7 days to 12 months) and permanent AF (>12 months), and age- and sex-matched 30 controls with sinus rhythm. Plasma levels of PRA and NT-pro-BNP were measured and presented as median (25th-75th percentiles). Echocardiographic examination was performed in all population. Variance and logistic regression analyses were also used for multiple comparisons and independent predictors, respectively. Results: Median NT-proBNP levels were higher in overall patients with AF than in controls [114 (63-165) vs 50 (38-58) pg/ml, p<0.001), but PRA level was comparable in both groups. Similarly, NT-proBNP levels were also higher in all subtypes of AF compared with controls (p<0.05). In addition, there was a significant difference in NT-proBNP level among recent, persistent and permanent AF subtypes (p=0.001).
    [Show full text]
  • Role of the Renin-Angiotensin-Aldosterone
    International Journal of Molecular Sciences Review Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension Natalia Muñoz-Durango 1,†, Cristóbal A. Fuentes 2,†, Andrés E. Castillo 2, Luis Martín González-Gómez 2, Andrea Vecchiola 2, Carlos E. Fardella 2,* and Alexis M. Kalergis 1,2,* 1 Millenium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8330025 Santiago, Chile; [email protected] 2 Millenium Institute on Immunology and Immunotherapy, Departamento de Endocrinología, Escuela de Medicina, Pontificia Universidad Católica de Chile, 8330074 Santiago, Chile; [email protected] (C.A.F.); [email protected] (A.E.C.); [email protected] (L.M.G.-G.); [email protected] (A.V.) * Correspondence: [email protected] (C.E.F.); [email protected] (A.M.K.); Tel.: +56-223-543-813 (C.E.F.); +56-223-542-842 (A.M.K.) † These authors contributed equally in this manuscript. Academic Editor: Anastasia Susie Mihailidou Received: 24 March 2016; Accepted: 10 May 2016; Published: 23 June 2016 Abstract: Arterial hypertension is a common condition worldwide and an important predictor of several complicated diseases. Arterial hypertension can be triggered by many factors, including physiological, genetic, and lifestyle causes. Specifically, molecules of the renin-angiotensin-aldosterone system not only play important roles in the control of blood pressure, but they are also associated with the genesis of arterial hypertension, thus constituting a need for pharmacological interventions. Chronic high pressure generates mechanical damage along the vascular system, heart, and kidneys, which are the principal organs affected in this condition.
    [Show full text]
  • Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
    International Journal of Molecular Sciences Review Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD Anastasia V. Poznyak 1,* , Dwaipayan Bharadwaj 2,3, Gauri Prasad 3, Andrey V. Grechko 4, Margarita A. Sazonova 5 and Alexander N. Orekhov 1,5,6,* 1 Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609 Moscow, Russia 2 Academy of Scientific and Innovative Research, CSIR-Institute of Genomics and Integrative Biology Campus, New Delhi 110067, India; [email protected] 3 Systems Genomics Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India; [email protected] 4 Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, 14-3 Solyanka Street, 109240 Moscow, Russia; [email protected] 5 Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia; [email protected] 6 Institute of Human Morphology, 3 Tsyurupa Street, 117418 Moscow, Russia * Correspondence: [email protected] (A.V.P.); [email protected] (A.N.O.) Abstract: Atherosclerosis has complex pathogenesis, which involves at least three serious aspects: inflammation, lipid metabolism alterations, and endothelial injury. There are no effective treatment options, as well as preventive measures for atherosclerosis. However, this disease has various severe complications, the most severe of which is cardiovascular disease (CVD). It is important to note, that CVD is among the leading causes of death worldwide. The renin–angiotensin–aldosterone system (RAAS) is an important part of inflammatory response regulation. This system contributes to Citation: Poznyak, A.V.; Bharadwaj, the recruitment of inflammatory cells to the injured site and stimulates the production of various D.; Prasad, G.; Grechko, A.V.; cytokines, such as IL-6, TNF-a, and COX-2.
    [Show full text]
  • The Renin-Angiotensin-Aldosterone System and The
    36 Heart (Supplement 3) 1996;76:36-44 The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides Heart: first published as 10.1136/hrt.76.3_Suppl_3.36 on 1 November 1996. Downloaded from A Mark Richards Natriuretic peptides and the renin- functions as a "clearance receptor", removing angiotensin-aldosterone system (RAAS) have natriuretic peptides from the circulation.5 reciprocal effects at multiple sites and in varied ANF and BNP stimulate cGMP production situations. They interact in health and cardio- through the NPR-A receptor. The NPR-B vascular disease to influence renal, endocrine, receptor is selective for CNP.6 The NPR-C and haemodynamic function and cardiovascu- (clearance receptor) binds all three of the lar cell growth. The atrial natriuretic peptide natriuretic peptides. Natriuretic peptides are (atrial natriuretic factor, ANF) discovered by also subject to clearance by enzymatic degra- De Bold in 19811 was cloned and sequenced dation. The neutral endopeptidase EC by molecular biological techniques in 1984.2 3A4'24'11 contributes to ANF clearance (and The related peptides, brain natriuretic peptide to a lesser extent BNP clearance) in humans.7 (BNP) and C-type natriuretic peptide (CNP), The biochemistry of natriuretic peptides is fur- were sequenced in 1988 and 1990, respec- ther detailed in a recent review.8 tively.34 The mature forms of the peptides The focus of the present review is the inter- share a common core structure consisting of a action of the cardiac natriuretic peptides with 17-amino acid ring with some conservation of the RAAS. Studies in humans will be amino acid residues between peptides (fig reviewed, with additional information from in 1).24 ANF is present at high concentrations in vitro or intact animal experiments where atrial tissue, and in lesser amounts in the cen- appropriate.
    [Show full text]
  • The Natriuretic Peptides System in the Pathophysiology of Heart Failure: from Molecular Basis to Treatment
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Archivio della ricerca- Università di Roma La Sapienza Clinical Science (2016) 130, 57–77 doi: 10.1042/CS20150469 The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment Massimo Volpe*†, Marino Carnovali‡ and Vittoria Mastromarino* *Cardiology Department, Clinical and Molecular Medicine Department, Sapienza University of Rome, 00189 Rome, Italy †IRCCS Neuromed, 86077 Pozzilli, IS, Italy ‡Rehabilitation Department, A.O. “G. Salvini” 20024 Garbagnate Milanese, Milan, Italy Abstract After its discovery in the early 1980s, the natriuretic peptide (NP) system has been extensively characterized and its potential influence in the development and progression of heart failure (HF) has been investigated. HF is a syndrome characterized by the activation of different neurohormonal systems, predominantly the renin–angiotensin (Ang)–aldosterone system (RAAS) and the sympathetic nervous system (SNS), but also the NP system. Pharmacological interventions have been developed to counteract the neuroendocrine dysregulation, through the down modulation of RAAS with ACE (Ang-converting enzyme) inhibitors, ARBs (Ang receptor blockers) and mineralcorticoid antagonists and of SNS with β-blockers. In the last years, growing attention has been paid to the NP system. In the present review, we have summarized the current knowledge on the NP system, focusing on its role in HF and we provide an overview of the pharmacological attempts to modulate NP in HF: from the negative results of the study with neprilysin (NEP) inhibitors, alone or associated with an ACE inhibitor and vasopeptidase inhibitors, to the most recently and extremely encouraging results obtained with the new pharmacological class of Ang receptor and NEP inhibitor, currently defined ARNI (Ang receptor NEP inhibitor).
    [Show full text]
  • Interaction of Renin–Angiotensin–Aldosterone System and Parathyroid Hormone; a New Dilemma Hamid Nasri1*
    Open Access http://www.jparathyroid.com Journal of Journal of Parathyroid Disease 2014,2(2),65–66 News and Views Interaction of renin–angiotensin–aldosterone system and parathyroid hormone; a new dilemma Hamid Nasri1* arious investigations have been detected, Implication for health policy/practice/research/ parathyroid hormone (parathormone) has been medical education implicated in regulating the renin–angiotensin– It is possible that physiological interaction between Valdosterone system (1-3). The system of renin– the renin–angiotensin–aldosterone system and angiotensin–aldosterone, in turn, has been involved in parathormone exists, however, this interaction requires regulating the calcium-regulatory hormones such as further investigations for better treatment of chronic vitamin D and parathormone. In fact, inappropriate action kidney disease. of both parathyroid hormone and the renin–angiotensin– aldosterone system may negatively influence skeletal health and cardiovascular (2-6). Funding/Support The observational studies such as reduced bone mineral No funding from any source. density and a higher rate of osteoporosis in patients with primary hyperaldosteronism and an elevated parathormone References levels which are lowered after clinically indicated surgical 1. Atchison DK, Westrick E, Szandzik DL, Gordish or medical treatment in these patients, is a human evidence KL, Beierwaltes WH. Parathyroid hormone-related describing the positive association between renin– protein stimulates plasma renin activity via its angiotensin–aldosterone system activity and parathormone anorexic effects on sodium chloride intake. Am J (1-5). Likewise, Treatment with spironolactone therapy Physiol Endocrinol Metab 2012; 303(4): E457-63. is associated with lower fracture risk in heart failure 2. Brown JM, Williams JS, Luther JM, Garg R, Garza (3-7).
    [Show full text]